Disorder Clinical Trials

4,742 recruitingLast updated: July 25, 2026

There are 4,742 actively recruiting disorder clinical trials across 95 countries. Studies span Not Applicable, Phase 2, Phase 1, Phase 3, Phase 4, Early Phase 1. Top locations include Boston, Massachusetts, United States, New York, New York, United States, Houston, Texas, United States. Updated daily from ClinicalTrials.gov.


Disorder Trials at a Glance

4,742 actively recruiting trials for disorder are listed on ClinicalTrialsFinder across 6 cities in 95 countries. The largest study group is Not Applicable with 2,510 trials, with the heaviest enrollment activity in Boston, New York, and Houston. Lead sponsors running disorder studies include Yale University, VA Office of Research and Development, and Stanford University.

Treatments under study

About Disorder Clinical Trials

Looking for clinical trials for Disorder? There are currently 2 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Disorder trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Disorder clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 4,742 trials

Recruiting

Screening for Social Determinants of Health (SDOH) and Cognitive Function in Individuals With History of Stroke

StrokeBrain DiseaseVascular Diseases+1 more
National Institute of Neurological Disorders and Stroke (NINDS)450 enrolled1 locationNCT06615973
Recruiting
Phase 3

A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)

Bipolar Disorder Type I With Mania
Bristol-Myers Squibb450 enrolled174 locationsNCT06929273
Recruiting

SMART-r: Substance Monitoring and Active Relapse Tracking Repository

AlcoholismSubstance-Related Disorders
National Institute on Drug Abuse (NIDA)10,000 enrolled1 locationNCT06676059
Recruiting
Phase 3

Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shift Work Disorder (SUSTAIN)

Shift-work DisorderExcessive Sleepiness
Axsome Therapeutics, Inc.520 enrolled49 locationsNCT06568367
Recruiting
Phase 1

Tirzepatide s Dopaminergic Effects in Alcohol Use Disorders (AUD)

Alcohol Use Disorder (AUD)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)176 enrolled1 locationNCT07559500
Recruiting
Phase 3

Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol

Major Depressive Disorder With Excessive Daytime Sleepiness Symptoms
Axsome Therapeutics, Inc.508 enrolled40 locationsNCT07484217
Recruiting

Data Collection Study of Pediatric and Adolescent Gynecology Conditions

Disorders of Sex Development (DSD)Pediatric and Adolescent Cancers of the Genital TractReproductive Endocrine Conditions in Puberty+1 more
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)11,000 enrolled1 locationNCT04717349
Recruiting
Phase 1

Environment and Alcohol: A Pilot Study

Alcohol Use Disorder
National Institute on Drug Abuse (NIDA)44 enrolled1 locationNCT06860607
Recruiting

Hepatic Lipid Metabolism-Alcohol Use Disorder

Alcohol Use Disorder
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)25 enrolled1 locationNCT07191561
Recruiting

SLC6A1-NDD Prospective Longitudinal Natural History Study

SLC6A1 Neurodevelopmental Disorder (NDD)Developmental and Epileptic Encephalopathies (DEE)
UCB Biopharma SRL60 enrolled3 locationsNCT07531511
Recruiting
Not Applicable

Tele-group Cognitive Behavioural Family Intervention for Individuals With Schizophrenia and Their Families (Definitive tgCBFI)

Schizophrenia and Related Disorders
The Hong Kong Polytechnic University200 enrolled6 locationsNCT07121166
Recruiting
Not Applicable

Evaluation of Depression Screening Methods Administered by Registered Nurses in Chronic Hemodialysis Patients

Depressive DisordersEnd-stage Chronic Kidney Disease Treated With Hemodialysis
Centre Hospitalier Annecy Genevois450 enrolled2 locationsNCT07651436
Recruiting
Phase 3

Cognitive Strategies in Early Psychosis 2

Major Depressive Disorder with Psychotic featuresCognitionPsychosis+6 more
University of Minnesota24 enrolled1 locationNCT07263022
Recruiting

Psychological Outcomes of Strategic Therapy in Adult Outpatients (POST Trial)

Mental Disorder
Società Scientifica di Psicoterapia Strategica450 enrolled2 locationsNCT07195266
Recruiting
Not Applicable

Virtual Reality-Enhanced Behavioral Activation for Older Adults With Depression

Depression - Major Depressive DisorderOlder Adults (65 Years and Older)Behavioral Activation Treatment+1 more
Stanford University30 enrolled1 locationNCT07188623
Recruiting
Phase 2

GLP-1R Agonist Treatment for Opioid Use Disorder

Opioid-use DisorderSubstance-Related DisordersOpioid+4 more
Milton S. Hershey Medical Center200 enrolled4 locationsNCT06548490
Recruiting
Not Applicable

Neurophysiological Investigation of the Approach-avoidance Axis in OCD: Applications to Neuromodulation

Obsessive Compulsive Disorder (OCD)Neuromodulation
Baylor College of Medicine10 enrolled2 locationsNCT06596447
Recruiting
Phase 3

Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder in Pediatric Patients

Irritability Associated With Autism Spectrum Disorder
Intra-Cellular Therapies, Inc.160 enrolled35 locationsNCT06690398
Recruiting
Phase 1

A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias

HypercholesterolaemiaMetabolic DiseaseDyslipidemias+7 more
CRISPR Therapeutics AG90 enrolled19 locationsNCT07491172
Recruiting
Not Applicable

Adaptive Coping Skills Training to Improve Psychological Distress Among Cardiorespiratory Failure Survivors

DepressionStressAnxiety+3 more
Duke University400 enrolled1 locationNCT06538246